Friday 6 November 2026 Export AQST’s income statement to Excel — free account

Aquestive Therapeutics, Inc.

AQST Healthcare Drug Manufacturers Specialty & Generic

Aquestive Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.5 million, down 22.6% from fiscal 2024.

Revenue: −41.0%
EPS: +6.14%
Free cash flow: +40.8%
Total debt: +69.5%

Quarter to September 2026, against a year earlier

3.58 0.08 −2.19%

Follow AQST

Alert me

Market cap: $460.0M
P/E: 0.0×
Fwd P/E: −7.7×
Dividend yield: —
F-score: 2/9
Altman Z: −2.19
Beneish M: −1.91
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	4	4	2	2	+8 more TTM periods Free account
ROE Full definition →	211.59%	121.12%	145.10%	178.61%
ROA Full definition →	(56.05%)	(69.29%)	(56.63%)	(63.99%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(85.35%)	(73.82%)	(67.38%)	(79.38%)
Average Days of Receivables Full definition →	39.27	62.94	49.86	145.55
Free Cash Flow per Share Full definition →	(0.32)	(0.37)	(0.36)	(0.50)
Free Cash Flow Full definition →	(40.69)	(45.95)	(44.32)	(52.99)
Capital Expenditures Full definition →	(0.93)	(0.58)	(0.48)	(0.56)
Other line items
Cash ROIC Full definition →	(57.90%)	(49.64%)	(43.54%)	(46.07%)
Accounts Receivable Turnover Full definition →	5.73	5.11	5.81	3.55
Accounts Payable Turnover Full definition →	1.72	1.70	1.52	0.92
Inventory Turnover Full definition →	2.23	2.30	2.41	3.04
Average Days of Payables Full definition →	190.13	183.54	236.20	587.42
Days of Inventory on Hand Full definition →	157.60	150.81	160.25	121.35
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	31.97%	29.38%	31.90%	38.59%
Selling, General and Administrative Expense of Revenue Full definition →	147.49%	135.17%	142.73%	179.25%
Share Based Compensation of Revenue Full definition →	17.85%	17.32%	16.62%	17.12%
Interest Coverage Full definition →	(3.73)	(3.23)	(3.34)	(4.15)
Operating CF/Net income Full definition →	0.50	0.58	0.64	0.63
Depreciation/Fixed assets Full definition →	1.99	2.54	2.88	2.97
Capex/Depreciation Full definition →	(0.11)	(0.06)	(0.04)	(0.05)
Revenue per Share Full definition →	0.39	0.43	0.41	0.42
Operating CF per Share Full definition →	(0.32)	(0.36)	(0.36)	(0.49)
Capex per Share Full definition →	(0.01)	0.00	0.00	(0.01)
Capex to Sales Full definition →	0.02	0.01	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly